Upcoming Events, New Facilities, Technical Updates, and Pilot Programs - Research Reports on Aetna, United Therapeutics, Quest Diagnostics, Cummins and Danaher

NEW YORK, October 8, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Aetna Inc. (NYSE: AET), United Therapeutics Corporation (NASDAQ: UTHR), Quest Diagnostics Inc. (NYSE: DGX), Cummins Inc. (NYSE: CMI) and Danaher Corp. (NYSE: DHR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7007-100free.

--
Aetna Inc. Research Reports
On October 1, 2014, Aetna Inc. (Aetna) announced that it will release its Q3 2014 results on Tuesday, October 28, 2014, at 6:00 a.m. ET, followed by a conference call at 8:00 a.m. ET on the same day. A live audio webcast of the call, as well as financial, statistical and other information related to the call, will be available via Aetna's Investor Information website. The full research reports on Aetna are available to download free of charge at:

http://www.analystsreview.com/Oct-08-2014/AET/report.pdf

--
United Therapeutics Corporation Research Reports
On October 3, 2014, United Therapeutics Corporation's (United Therapeutics) stock slightly moved down 0.04% to settle at $129.41. After opening at $130.10, the shares oscillated between $128.59 and $131.69. A total of 1.35 million shares changed hands during the session, higher than its 30-day average trading volume of 1.21 million shares. The stock closed above its 50-day and 200-day moving averages of $108.47 and $101.13, respectively. The full research reports on United Therapeutics are available to download free of charge at:

http://www.analystsreview.com/Oct-08-2014/UTHR/report.pdf

--
Quest Diagnostics Inc. Research Reports
On October 2, 2014, Quest Diagnostics Inc. (Quest Diagnostics) reported the opening of its new, state-of-the-art clinical test laboratory in Marlborough, Massachusetts with a ribbon-cutting ceremony attended by top health care leaders and state officials, including Congresswoman Niki Tsongas, State Representative Danielle Gregoire and Marlborough Mayor Arthur Vigeant. The facility, which has been dubbed the "lab of the future" for its innovative use of technology and building design, will provide a broad range of advanced clinical testing services to people in New England. Physicians and medical faculty employed by UMass Memorial Medical Group and the University of Massachusetts Medical School will provide scientific leadership for several aspects of laboratory testing for the new facility. The facility is expected to employ 1,350 health care professionals after becoming fully operational in Q2 2015. The full research reports on Quest Diagnostics are available to download free of charge at:

http://www.analystsreview.com/Oct-08-2014/DGX/report.pdf

--
Cummins Inc. Research Reports
On October 2, 2014, Cummins Inc. (Cummins) reported that Bartholomew Consolidated School Corporation (BCSC), with support from R.E.A.D.S. (Recognizing Educating and Advocating for Dyslexic Students), the MA Rooney Foundation and representatives of Cummins launched the pilot program, "Read by 3 Columbus." The program aims to develop stronger reading skills among children. Implemented at the start of the 2014-2015 school year, the Columbus program is being piloted in six kindergarten classrooms at Taylorsville Elementary and Columbus Signature Academy-Lincoln Campus. The Company informed that the impetus for launching the pilot in Columbus, Indiana came from R.E.A.D.S. which highlighted the need to help dyslexic children in the community. The full research reports on Cummins are available to download free of charge at:

http://www.analystsreview.com/Oct-08-2014/CMI/report.pdf

--
Danaher Corp. Research Reports
According to Danaher Corp.'s (Danaher) Investor Events section, the Company is scheduled to host an Investor and Analyst Meeting on Thursday, December 11, 2014. At the meeting, Danaher's management team, including President and CEO, Tom Joyce, and Executive Vice President and CFO, Dan Comas, will present an update on the state of the Company as well as its outlook for 2014. The full research reports on Danaher are available to download free of charge at:

http://www.analystsreview.com/Oct-08-2014/DHR/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED